Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:525-530
Published online before print July 16, 2007, doi: 10.1161/HYPERTENSIONAHA.107.088948
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
50/3/525    most recent
HYPERTENSIONAHA.107.088948v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hristovska, A.-M.
Right arrow Articles by Jensen, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hristovska, A.-M.
Right arrow Articles by Jensen, B. L.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2007;50:525.)
© 2007 American Heart Association, Inc.


Original Articles

Prostaglandin E2 Induces Vascular Relaxation by E-Prostanoid 4 Receptor-Mediated Activation of Endothelial Nitric Oxide Synthase

Ana-Marija Hristovska; Lasse E. Rasmussen; Pernille B.L. Hansen; Susan S. Nielsen; Rolf M. Nüsing; Shuh Narumiya; Paul Vanhoutte; Ole Skøtt; Boye L. Jensen

From the Department of Physiology and Pharmacology (A-M.H., L.E.R., P.B.L.H., S.S.N., O.S., B.L.J.), University of Southern Denmark, Odense, Denmark; Institute of Clinical Pharmacology (R.M.N.), Johann Wolfgang Goethe-University, Frankfurt, Germany; Department of Pharmacology (P.V.), University of Hong Kong, Hong Kong; and the Department of Pharmacology (S.N.), Kyoto University Faculty of Medicine, Kyoto, Japan.

Correspondence to Boye L. Jensen, Department of Physiology and Pharmacology, University of Southern Denmark, Winslowparken 21, 3, DK-5000 Odense C, Denmark. E-mail: bljensen{at}health.sdu.dk

The present experiments were designed to test the hypothesis that prostaglandin (PG) E2 causes vasodilatation through activation of endothelial NO synthase (eNOS). Aortic rings from mice with targeted deletion of eNOS and E-prostanoid (EP) receptors were used for contraction studies. Blood pressure changes in response to PGE2 were measured in conscious mice. Single doses of PGE2 caused concentration-dependent relaxations during contractions to phenylephrine (EC50=5*10–8 mol/L). Relaxation after PGE2 was absent in rings without endothelium and in rings from eNOS–/– mice and was abolished by NG-nitro-L-arginine methyl ester and the soluble guanylate cyclase inhibitor 1H1,2,4-oxadiazolo-[4,3-a]quinoxalin-1-one. In PGE2-relaxed aortic rings, the cGMP content increased significantly. PGE2-induced relaxations were abolished by the EP4 receptor antagonist AE3–208 (10–8 mol/L) and mimicked by an EP4 agonist (AE1–329, 10–7 mol/L) in the presence of endothelium and eNOS only. Relaxations were attenuated significantly in rings from EP4–/– mice but normal in EP2–/–. Inhibitors of the cAMP-protein kinase A pathway attenuated, whereas the inhibitor of protein phosphatase 1C, calyculin (10–8 mol/L), abolished the PGE2-mediated relaxation. In aortic rings, PGE2 dephosphorylated eNOS at Thr495. Chronically catheterized eNOS–/– mice were hypertensive (137±3.6 mm Hg, n=13, versus 101±3.9 mm Hg, n=9) and exhibited a lower sensitivity of blood pressure reduction in response to PGE2 compared with wild-type mice. There was no difference in the blood pressure response to nifedipine. These findings show that PGE2 elicits EP4 receptor-mediated, endothelium-dependent stimulation of eNOS activity by dephosphorylation at Thr495 resulting in guanylyl cyclase–dependent vasorelaxation and accumulation of cGMP in aortic rings.


Key Words: cyclooxygenase • cGMP • hypertension • phosphorylation • thromboxane




This article has been cited by other articles:


Home page
IOVSHome page
T. Dalsgaard, C. Kroigaard, T. Bek, and U. Simonsen
Role of Calcium-Activated Potassium Channels with Small Conductance in Bradykinin-Induced Vasodilation of Porcine Retinal Arterioles
Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3819 - 3825.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Di Francesco, L. Totani, M. Dovizio, A. Piccoli, A. Di Francesco, T. Salvatore, A. Pandolfi, V. Evangelista, R. A. Dercho, F. Seta, et al.
Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-{alpha} Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells
Circ. Res., February 27, 2009; 104(4): 506 - 513.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Jia, X. Guo, H. Zhang, M.-H. Wang, Z. Dong, and T. Yang
Microsomal Prostaglandin Synthase-1-Derived Prostaglandin E2 Protects Against Angiotensin II-Induced Hypertension via Inhibition of Oxidative Stress
Hypertension, November 1, 2008; 52(5): 952 - 959.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. H.C. Tang, B. L. Jensen, O. Skott, G. P.H. Leung, M. Feletou, R. Y.K. Man, and P. M. Vanhoutte
The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats
Cardiovasc Res, April 1, 2008; 78(1): 130 - 138.
[Abstract] [Full Text] [PDF]